![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire](https://mms.businesswire.com/media/20201005005212/en/826961/5/AermonyRespiClick_ENG.jpg)
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
![Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions](https://s40123.pcdn.co/wp-content/uploads/2022/01/shutterstock_1424969885-700x466.jpg)
Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions
![Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company. Stock Photo | Adobe Stock Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company. Stock Photo | Adobe Stock](https://as2.ftcdn.net/v2/jpg/04/36/57/51/1000_F_436575157_YIgOV2zm0fdJmC2d6gTPtCHosyfUzJNN.jpg)
Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company. Stock Photo | Adobe Stock
Teva Pharmaceutical Industries Ltd. - On Thursday May 12, Doug Sommerville General Manager Teva Canada, John Jacobs GM for Teva Canada Innovation, Ben Gray VP, General Counsel, Bennett Lee and Houri Ohan
![Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA® Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®](http://photos.newswire.ca/images/20151215_C6454_PHOTO_EN_564829.jpg)
Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®
![Teva Pharmaceuticals to pay $4.2 billion opioid settlement; New York to get $523 million - CBS New York Teva Pharmaceuticals to pay $4.2 billion opioid settlement; New York to get $523 million - CBS New York](https://assets1.cbsnewsstatic.com/hub/i/r/2022/11/03/fd55bd2e-7a7b-4bab-a11b-9f38d31c7335/thumbnail/1280x720/cd7e258c4fc75b138f943f96c466bae4/8504a0318bd6b193a07d97db6e4f737d.jpg)